Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients
CONCLUSIONS: This study provided valuable insights into the early integration of BNCT into routine clinical practice, highlighting its efficacy and safety. Technical improvements are needed to ensure precise dose administration. Ongoing prospective studies, such as the phase II REBIVAL study, will further elucidate the role of BNCT in recurrent head and neck cancer.PMID:38580084 | DOI:10.1016/j.ijrobp.2024.03.041
Source: Health Physics - Category: Physics Authors: Katsumi Hirose Mariko Sato Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | Health Insurance | Insurance | Japan Health | Pharyngeal Cancer | Physics | Radiation Therapy | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology